Our guest is Mark Schmeizl!

Mark Connor! Learn more about #GPCRs and life as an academic wearing different hats.

June 2022 "June 15, 2022 06:30 AM EDT - In 2016, Abbie Celniker was promoted to partner at Third Rock Ventures as the firm raised just over $600 million for its fourth fund. Since then, Celniker has helped usher in an additional fund and headed a few startups as interim CEO. Coming on its 15th year, Third Rock Ventures announced its sixth fund today — and largest one by far — at a whopping $1.1 billion. Adding it all up, Third Rock has raised $3.8 billion since its inception. That money has gone to some 60 biotechs, much of it as early funding." Read more at the source #DrGPCR #GPCR #IndustryNews

Stein , Cornelia Heindrich , Kirsten Wittke , Claudia Kedor , Laura Kim , Helma Freitag , Anne Krüger , Markus Tölle , Carmen Scheibenbogen Tags GPCR-antibodies , Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

GPCR Podcast << Back to podcast list Mark Schmeizl About Mark Schmeizl Mark leverages 30 years in various Mark believes professional placement should be about matching talented people with companies where they Mark Schmeizl on the web Website LinkedIn Dr.

Mark Connor About Dr. Mark Connor Undergraduate BSc with Honours in Pharmacology from University of Sydney (1987, snake neurotoxins Mark Connor on the web Researchers Twitter Google Scholar Dr.